Alira Health

Alira Health

CMC Solutions

CDMO Selection and Outsourcing Support

Our technical experts help you develop and execute your clinical CMC strategy

Partner with our experienced CMC team to find, evaluate, and select a CDMO that fits your needs. We create tailored evaluation criteria focused on your product and strategic business priorities.
  • Identify, evaluate, and select CDMOs based on the product profile and your company’s priorities 
  • Review and help negotiate master services agreements 
  • Provide technical oversight of the CDMO and advocate on behalf of the client to deliver clinical product on time  
  • Provide Quality oversight of all GMP operations 
  • Provide Regulatory/CMC strategy and advice captured and delivered in a dossier for FDA or EMA 

We also support and oversee the following processes:

  • Cell line, process, and formulation development 
  • Development and validation of analytical methods for in-process, release, and stability testing 
  • Design specifications for release of bulk drug substance and products 
  • GMP Drug Substance and Drug Product manufacturing 
  • Clinical packaging, labeling, and distribution 
  • Project Management  
  • Commercial manufacturing 

Why choose Alira Health for CDMO selection and oversight?

As our client, you can rely on our dedicated, knowledgeable team to lead and support your outsourcing activities. You’ll benefit from our: 

  • Strong technical management at all stages from preclinical process development through manufacturing 
  • Commitment to client advocacy with vendors that drives holistic solutions tailored to your business needs and goals 
  • Full spectrum development support from product decision through clinical trials, process validation, and commercial manufacturing 
  • Packaging, labeling, and shipping support and management 

CMC Outsourcing News

News April 29, 2024
Alira Health Advises Trill Impact Entering a Strategic Alliance with TT medic
We are pleased to have been a Commercial Due Diligence advisor for Trill Impact, a pioneering Impact House with around EUR 1.2 billion in assets under management, joining forces with(...)
CDD CDMO MedTech
Articles February 27, 2024
The 2024 Global Medtech Contract Manufacturing Report: Executive Summary
Executive summary of our 2024 global medtech contract manufacturing report detailing global trends and investment activity and in-depth analysis of the European outsourcing market.
CDMO MedTech
News February 26, 2024
Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report
Alira Health announced the release of the 2024 Global Medtech Contract Manufacturing Report. This report offers a comprehensive analysis of trends in the global medtech contract manufacturing(...)
CDMO MedTech
Reports February 25, 2024
The 2024 Global Medtech Contract Manufacturing Report
Discover the trends in the world of medical device CDMOs and their meaning for the industry in 2024 and beyond.
CDMO MedTech
Webinars January 31, 2024
Medtech CDMO: Market and M&A Global Trends in 2024
This webinar replay investigates the current state of the global medtech CDMO industry and highlight Europe as a promising frontier for consolidation.
CDMO MedTech
News January 26, 2024
Alira Health’s CDD Supports Alcami Acquisition of Pacific Pharmaceutical Services
We are pleased to have been an advisor on Alcami’s acquisition of Pacific Pharmaceutical Services (PPS). Alira Health advised Alcami, a leading Contract Development Manufacturing(...)
CDD CDMO Pharma
Events January 22, 2024
Pharmapack Europe
Connect with our Drug Delivery Systems and CDMO experts Aude Ouensanga, Giulia Valsecchi, and Michal Raciborski on site at Pharmapack Europe.
CDMO Drug Delivery Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.